FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956176569> ?p ?o ?g. }

• W2956176569 endingPage "e1449" @default.
• W2956176569 startingPage "e1443" @default.
• W2956176569 abstract "There are limited data on the clinical benefits of adding surgical resection in patients with focally progressive gastrointestinal stromal tumor (GIST). This study aims to compare the clinical outcomes of resection plus imatinib dose escalation or maintenance (S group) with imatinib dose escalation alone (NS group) in patients with advanced GIST following focal progression (FP) with standard doses of imatinib.A total of 90 patients with advanced GISTs who experienced FP with standard doses of imatinib were included in this retrospective analysis. The primary endpoints were time to imatinib treatment failure (TTF) and overall survival (OS).Compared with the NS group (n = 52), patients in the S group (n = 38) had a higher proportion of primary tumor site involvement and lower tumor burden at FP. With a median follow-up duration of 31.0 months, patients in the S group had significantly better TTF and OS than patients in the NS group (median TTF: 24.2 vs. 6.5 months, p < .01; median OS: 53.2 vs. 35.1 months, p = .009). Multivariate analysis showed that S group independently demonstrated better TTF (hazard ratio [HR], 0.29; p < .01) and OS (HR, 0.47; p = .01). Even after applying inverse probability of treatment-weighting adjustments, S group demonstrated significantly better TTF (HR, 0.36; p < .01) and OS (HR, 0.58; p = .049).Our results suggested that resection following FP with standard doses of imatinib in patients with advanced GIST provides additional benefits over imatinib dose escalation alone.This is the first study to compare the clinical outcomes of resection plus imatinib dose escalation or maintenance (S group) with imatinib dose escalation alone (NS group) in patients with advanced gastrointestinal stromal tumor (GIST) following focal progression (FP) with standard doses of imatinib. These findings suggest that resection can be safely performed following FP, and the addition of surgical resection provides further clinical benefit over imatinib dose escalation alone. Based on these results, the authors recommend resection following FP in patients with advanced GIST provided that an experienced multidisciplinary team is involved in the patient's treatment." @default.
• W2956176569 created "2019-07-23" @default.
• W2956176569 creator A5000399534 @default.
• W2956176569 creator A5000505018 @default.
• W2956176569 creator A5005441512 @default.
• W2956176569 creator A5005925636 @default.
• W2956176569 creator A5007899105 @default.
• W2956176569 creator A5014278842 @default.
• W2956176569 creator A5017077151 @default.
• W2956176569 creator A5017172069 @default.
• W2956176569 creator A5019154969 @default.
• W2956176569 creator A5052598774 @default.
• W2956176569 creator A5085952795 @default.
• W2956176569 creator A5089384315 @default.
• W2956176569 date "2019-07-17" @default.
• W2956176569 modified "2023-10-17" @default.
• W2956176569 title "Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses" @default.
• W2956176569 cites W1969728666 @default.
• W2956176569 cites W1978950465 @default.
• W2956176569 cites W1981491302 @default.
• W2956176569 cites W1999322661 @default.
• W2956176569 cites W2015015957 @default.
• W2956176569 cites W2015658158 @default.
• W2956176569 cites W2037290765 @default.
• W2956176569 cites W2039631420 @default.
• W2956176569 cites W2068926954 @default.
• W2956176569 cites W2095531542 @default.
• W2956176569 cites W2110818436 @default.
• W2956176569 cites W2115504770 @default.
• W2956176569 cites W2116922255 @default.
• W2956176569 cites W2118817085 @default.
• W2956176569 cites W2119505091 @default.
• W2956176569 cites W2139511378 @default.
• W2956176569 cites W2145131634 @default.
• W2956176569 cites W2155741608 @default.
• W2956176569 cites W2158945054 @default.
• W2956176569 cites W2171620774 @default.
• W2956176569 cites W2294033795 @default.
• W2956176569 cites W2462372397 @default.
• W2956176569 cites W2601222128 @default.
• W2956176569 cites W2609286107 @default.
• W2956176569 cites W2805725835 @default.
• W2956176569 cites W4238208852 @default.
• W2956176569 doi "https://doi.org/10.1634/theoncologist.2019-0009" @default.
• W2956176569 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6975948" @default.
• W2956176569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31315961" @default.
• W2956176569 hasPublicationYear "2019" @default.
• W2956176569 type Work @default.
• W2956176569 sameAs 2956176569 @default.
• W2956176569 citedByCount "5" @default.
• W2956176569 countsByYear W29561765692019 @default.
• W2956176569 countsByYear W29561765692020 @default.
• W2956176569 countsByYear W29561765692023 @default.
• W2956176569 crossrefType "journal-article" @default.
• W2956176569 hasAuthorship W2956176569A5000399534 @default.
• W2956176569 hasAuthorship W2956176569A5000505018 @default.
• W2956176569 hasAuthorship W2956176569A5005441512 @default.
• W2956176569 hasAuthorship W2956176569A5005925636 @default.
• W2956176569 hasAuthorship W2956176569A5007899105 @default.
• W2956176569 hasAuthorship W2956176569A5014278842 @default.
• W2956176569 hasAuthorship W2956176569A5017077151 @default.
• W2956176569 hasAuthorship W2956176569A5017172069 @default.
• W2956176569 hasAuthorship W2956176569A5019154969 @default.
• W2956176569 hasAuthorship W2956176569A5052598774 @default.
• W2956176569 hasAuthorship W2956176569A5085952795 @default.
• W2956176569 hasAuthorship W2956176569A5089384315 @default.
• W2956176569 hasBestOaLocation W29561765691 @default.
• W2956176569 hasConcept C121608353 @default.
• W2956176569 hasConcept C126322002 @default.
• W2956176569 hasConcept C141071460 @default.
• W2956176569 hasConcept C143998085 @default.
• W2956176569 hasConcept C167135981 @default.
• W2956176569 hasConcept C16930146 @default.
• W2956176569 hasConcept C17923572 @default.
• W2956176569 hasConcept C207103383 @default.
• W2956176569 hasConcept C2775922572 @default.
• W2956176569 hasConcept C2777007597 @default.
• W2956176569 hasConcept C2777583451 @default.
• W2956176569 hasConcept C2778729363 @default.
• W2956176569 hasConcept C2779490328 @default.
• W2956176569 hasConcept C3019892230 @default.
• W2956176569 hasConcept C44249647 @default.
• W2956176569 hasConcept C71924100 @default.
• W2956176569 hasConcept C90924648 @default.
• W2956176569 hasConceptScore W2956176569C121608353 @default.
• W2956176569 hasConceptScore W2956176569C126322002 @default.
• W2956176569 hasConceptScore W2956176569C141071460 @default.
• W2956176569 hasConceptScore W2956176569C143998085 @default.
• W2956176569 hasConceptScore W2956176569C167135981 @default.
• W2956176569 hasConceptScore W2956176569C16930146 @default.
• W2956176569 hasConceptScore W2956176569C17923572 @default.
• W2956176569 hasConceptScore W2956176569C207103383 @default.
• W2956176569 hasConceptScore W2956176569C2775922572 @default.
• W2956176569 hasConceptScore W2956176569C2777007597 @default.
• W2956176569 hasConceptScore W2956176569C2777583451 @default.
• W2956176569 hasConceptScore W2956176569C2778729363 @default.
• W2956176569 hasConceptScore W2956176569C2779490328 @default.
• W2956176569 hasConceptScore W2956176569C3019892230 @default.

• next